Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ï?? Patients aged 18-60 years of either sex with a clinical diagnosis of Tinea corporis and/or Tinea cruris with ï?? Patients with Global assessment score of >= 5 with positive KOH mount ï?? Patients who will give consent and are able to do follow up
Exclusion criteria
Exclusion criteria: ï?? Immuno-compromised patients ï?? Patients with extensive Dermatophytosis, other forms of tinea infections, superadded bacterial infection ï?? Patients with contact dermatitis, atopic dermatitis, psoriasis, other skin diseases ï?? Patients with a history of hypersensitivity to allylamine antifungals ï?? Patients who received topical antifungal within 1 week and systemic antifungals within 4 weeks prior to enrolment ï?? Patients with a known history or clinical evidence of bleeding disorders, severe systemic illness and uncontrolled diabetes mellitus ï?? Pregnant and lactating females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of achieved complete clearance among groups at the end of treatmentTimepoint: Baseline and after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| a. Comparison of achieved clinical cure among groups at the end of treatment b. Comparison of achieved Mycological cure among groups at the end of treatment c. Comparison of relapse among groups at the end of treatment d. Improvement in DLQI Timepoint: before and After study | — |
Countries
India
Contacts
National Institute of Unani Medicine